Yes, it is. When Rybelsus is administered, it acts as a glucagon-like peptide (GLP-1) receptor agonist, and it slows down gastric emptying, which can cause gastroparesis.
Gastroparesis is described as the partial or complete paralysis of the stomach. When this happens, your stomach digests food slower, and sometimes, it doesn’t digest at all. Gastroparesis is untreatable, and it can make people suffer chronically from abdominal pain, nausea, vomiting, and more.
A gastroparesis diagnosis after Rybelsus treatment might make you eligible for a claim. We’ll help you figure it out. Prepare your medical records and reach out to our team as soon as you can. If you are eligible, we’ll put you in touch with an attorney who is experienced in cases like these.